Centene Swings to $2.19 EPS in Q2, Raises Cash Flow, and Plans Major Workforce Cuts
CNC has more than doubled off its 52-week low of $25.075.
Summary
Centene reported Q2 2026 GAAP EPS of $2.19, a dramatic swing from a loss of $0.51 a year ago, fueled by a much lower medical cost ratio and strong cash flow. The company also announced a large voluntary separation program that will cost $315–$365 million in severance.
Key Events · Earnings and Guidance · CNC
-
Earnings Swing to Profit
Q2 2026 GAAP diluted EPS of $2.19 vs. a loss of $0.51 in Q2 2025. Adjusted diluted EPS was $2.51 vs. a loss of $0.16.
-
Health Benefits Ratio Improves Sharply
HBR fell to 89.6% from 93.0% a year ago, driven by Marketplace pricing actions, favorable risk adjustment, and no Medicare Advantage premium deficiency reserve in 2026.
-
Massive Workforce Reduction Planned
A voluntary separation program will incur $315M–$365M in severance costs in H2 2026, part of enterprise optimization efforts.
-
Operating Cash Flow Surges
Operating activities provided $3.6B in Q2 2026, up from $3.3B in the first half of 2025, aided by timing of pass-through payments.
Analysis · CNC · Finance
A sharp earnings turnaround defined Centene's Q2 2026, with GAAP diluted EPS reaching $2.19 compared to a loss of $0.51 a year ago. The dramatic improvement stemmed from a much lower health benefits ratio—89.6% versus 93.0%—reflecting better pricing and risk adjustment in the Marketplace business, along with the absence of a Medicare Advantage premium deficiency reserve that had burdened 2025 results. Operating cash flow surged to $3.6 billion, and the company aggressively reduced debt by $1.3 billion. However, a voluntary separation program was also announced, which will trigger $315–$365 million in severance costs in the second half of 2026, signaling a major cost-cutting push amid ongoing membership declines and regulatory headwinds. While the results handily beat the prior-year period and suggest pricing actions are taking hold, the workforce reduction and membership losses keep the outlook mixed.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CNC was trading at $67.38 on NYSE in the Finance sector, with a market capitalization of approximately $31.6B. The 52-week trading range was $25.08 to $69.36. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.